HomeTagsJacobio

Jacobio

Biotechnology

Jacobio Receives IND Approval for Aurora A Inhibitor JAB-2485 from FDA

PR Newswire - January 17, 2022

Jacobio's self-developed global first-in-class drug Aurora A inhibitor JAB-2485 received IND (Investigational New Drug) from the FDA (Food and Drug Administration) in US. Jacobio...

Internet Of Things (IOT)

Jacobio Receives IND Approval for Combination Therapy of KRAS G12C and Cetuximab Injection in China

PR Newswire - December 6, 2021

Jacobio Pharma (1167.HK) has received the Investigational New Drug (the "IND") approval of the combination therapy of KRAS G12C inhibitor JAB-21822 and Cetuximab injection...